Stocks
Mirum Pharmaceuticals, Inc.MIRM
NASDAQHealthcareBiotechnology$80.39
Price as of · delayed, not real-time
Mirum Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapies for rare liver diseases. Its lead product, Livmarli, targets cholestatic pruritus in Alagille syndrome and progressive familial intrahepatic cholestasis, with a growing pipeline addressing other rare conditions. Investors track MIRM for its commercial execution in a niche market and the potential expansion of its approved drug into additional indications.
52W Range: $63.23-$130.00
Congressional Interest in Mirum Pharmaceuticals, Inc. (MIRM)
No congressional trades have been disclosed for Mirum Pharmaceuticals, Inc. (MIRM) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading MIRM?
No congressional trades found for this stock.